Teijin Limited, together with its subsidiaries, engages in advanced fibers, plastics and films, composites, healthcare, and IT businesses worldwide. It operates through two segments, Materials Business Field and Healthcare Business Field. The company offers para-aramid, meta-aramid, polyester, polyethylene naphthalate (PEN), and flame-resistant fibers; artificial leather; carbon fibers and intermediate materials; LIB separators; and carbon fiber reinforced composites. It also provides polycarbonate (PC) resins, PC/ABS and PC/AS polymer alloys, PEN resins, polyethylene terephthalate (PET) resins, polybutylene naphthalete resins, polyphenylene sulfide (PPS) compound resins, plastic glazing resins, flame retardants, polyester films, PET and PEN films, processed films, raw materials, and polymers. In addition, the company offers Bonalon and Onealfa for the treatment of osteoporosis; Synvisc to treat knee osteoarthritis pain; sonic accelerated fracture healing systems; Mucosolvan, an expectorant; Alvesco, an inhaled corticosteroid agent for asthma; oxygen concentrators for home oxygen therapy; continuous positive airway pressure units; NIP NASAL, a non-invasive positive pressure ventilator; AutoSet CS, an adaptive servo-ventilator; Feburic to treat hyperuricemia and gout; Tricor for hyperlipidemia; Venilon for intravenous immunoglobulin preparation; and home healthcare services, as well as produces and rents home healthcare devices. Further, it trades in and sells fibrous raw materials, textiles and apparels, industrial textiles and materials, and performance polymer products. Additionally, the company provides IT services for the healthcare field and enterprises; Web-based enterprise resource planning software package; and e-comics distribution and e-commerce services. Teijin Limited was founded in 1918 and is headquartered in Tokyo, Japan.
Read More
